BIOANALYTICAL SERVICES
Tailored bioanalytical services for preclinical to clinical studies, primarily for large molecules, biosimilars, peptides, and oligonucleotides.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
With the speed and flexibility of a small company and the experience and quality of a large one, Mercodia strives to have deep understanding of your project’s specific needs from an early stage to ensure the best value while providing a cost-effective service. Mercodia specializes, but is not limited to large molecules, peptides and oligonucleotides, and use a wide range of tools and platforms including ELISA, MSD, and surface plasmon resonance (SPR) using Biacore™ technology. During planning and execution, all projects have access to expertise in product development, quality assurance, quality control, and project management according to the project’s requirements. Mercodia is fully compliant with GLP and relevant FDA, EMA, and ICH guidelines, and offers best-in-class regulatory consultancy. Mercodia's bioanalytical services allows easy access to the company's expert team, offering rapid turnaround times and data you can trust.
- PK and PD analysis
- Assay development and optimization
- Custom production
- Consultancy
- Biomarker analysis
- Immunogenicity testing
- Reagent characterization and control
Reliable and timely bioanalytical services: Empowering drug development journey
In this application note, Mercodia highlights itsreliable and timely bioanalytical services for supporting drug development journeys. With over 30 years of experience, Mercodia offers comprehensive services for preclinical and clinical studies, including immunoassays and ligand-binding assays for various analyses. Its expert team designs cost- and time-effective bioanalytical strategies, utilizing tools such as ELISA, MSD technology, and Biacore™ technology.
Risk mitigation in bioanalysis to maintain the integrity of drug development studies
In this video, Mercodia presents a webinar featuring Tanja Jarhede, Senior Scientist, who discusses common challenges faced in developing ligand binding assays (LBA). LBAs are crucial for quantifying biopharmaceuticals and biomarkers, as well as assessing immunogenicity in preclinical and clinical studies. The presentation emphasizes key considerations for building a robust assay with high specificity and selectivity, drawing from Mercodia's extensive experience in the field.
Mercodia's services for immunoassay development and clinical studies
This video introduces Mercodia, a trusted bioanalytical service partner with over 30 years of experience in immunoassay development and manufacturing. The company offers services for preclinical and clinical studies using proprietary immunoassays and other ligand-binding assays for pharmacokinetics, pharmacodynamics, immunogenicity, and biomarker analysis of proteins, peptides, and oligonucleotides. They also provide additional services such as assay development and validation of custom-made and commercially available assays. Mercodia is GLP and GCP certified and fully compliant with FDA, EMA, and ICH guidelines.
New bioanalytical service lab: How Mercodia is helping to advance drug development
Learn about Mercodia’s new bioanalytical service lab in Winston Salem, NC, USA, in this interview with Jörgen Dahlström, CEO of Mercodia. Find out how partnering with Mercodia enables drug developers worldwide to benefit from cost effective and on-time results in bioassay testing for preclinical and clinical programs, as well as solutions needed to develop and commercialize products.
Interview filmed at the AAPS National Biotechnology Conference 2023.
Want the latest expert interviews, articles, webinars, virtual summits and more direct to your inbox? Become a SelectScience member for free today>>
